European Journal of Neurology

Article	Citations
Amyotrophic lateral sclerosis: a clinical review	480
Acute‐onset smell and taste disorders in the context of COVID‐19: a pilot multicentre polymerase chain reaction based case–control study	229
Does SARS‐Cov‐2 invade the brain? Translational lessons from animal models	194
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision	167
Neuropsychiatric symptoms and quality of life in Spanish patients with Alzheimer’s disease during the COVID‐19 lockdown	136
Two patients with acute meningoencephalitis concomitant with SARS‐CoV‐2 infection	122
Stroke care during the COVID‐19 pandemic: experience from three large European countries	121
COVID‐19‐related encephalopathy: a case series with brain FDG‐positron‐emission tomography/computed tomography findings	120
Neurological outcome and quality of life 3 months after COVID‐19: A prospective observational cohort study	113
Long‐term efficacy and safety of erenumab in migraine prevention: Results from a 5‐year, open‐label treatment phase of a randomized clinical trial	112
Cognitive decline among individuals with history of mild symptomatic SARS‐CoV‐2 infection: A longitudinal prospective study nested to a population cohort	109
Cerebral venous thrombosis and severe acute respiratory syndrome coronavirus‐2 infection: A systematic review and meta‐analysis	107
Encephalitis as a neurological complication of COVID‐19: A systematic review and meta‐analysis of incidence, outcomes, and predictors	102
Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID‐19 and associated with neurological symptoms and disease severity	101
Cytokine release syndrome‐associated encephalopathy in patients with COVID‐19	98
COVID‐19 in multiple sclerosis patients: susceptibility, severity risk factors and serological response	94
Headache as an acute and post‐COVID‐19 symptom in COVID‐19 survivors: A meta‐analysis of the current literature	87
Patterns of smell recovery in 751 patients affected by the COVID‐19 outbreak	85
A systematic review of neurological manifestations of SARS‐CoV‐2 infection: the devil is hidden in the details	83
Neurological autoimmune diseases following vaccinations against SARS‐CoV‐2: a case series	81
Post‐SARS‐CoV‐2‐vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency	81
The international European Academy of Neurology survey on neurological symptoms in patients with COVID‐19 infection	80
Prevalence, clinical characteristics and outcomes of Guillain−Barré syndrome spectrum associated with COVID‐19: A systematic review and meta‐analysis	79
Miller‐Fisher syndrome after SARS‐CoV‐2 infection	77
Impact of the COVID‐19 outbreak on acute stroke pathways – insights from the Alsace region in France	76

Neurological manifestations and neuro‐invasive mechanisms of the severe acute respiratory syndrome coronavirus type 2	73
Emergency room neurology in times of COVID‐19: malignant ischaemic stroke and SARS‐CoV‐2 infection	70
Disability through COVID‐19 pandemic: neurorehabilitation cannot wait	69
European Academy of Neurology guideline on the management of medication‐overuse headache	68
COVID‐19 and herpes zoster co‐infection presenting with trigeminal neuropathy	65
European Stroke Organisation and European Academy of Neurology joint guidelines on post‐stroke cognitive impairment	63
Neuropathological findings from COVID‐19 patients with neurological symptoms argue against a direct brain invasion of SARS‐CoV‐2: A critical systematic review	63
European guideline and expert statements on the management of narcolepsy in adults and children	61
COVID‐19 and ischemic stroke	58
A European Academy of Neurology guideline on medical management issues in dementia	56
Guillain–Barré syndrome associated with SARS‐CoV‐2 infection. A systematic review	56
Neurological outcomes 1 year after COVID‐19 diagnosis: A prospective longitudinal cohort study	56
Increased risk of acute stroke among patients with severe COVID‐19: a multicenter study and meta‐analysis	55
SARS‐CoV‐2 and Guillain–Barré syndrome: AIDP variant with a favourable outcome	54
Predictive factors for a severe course of COVID‐19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival	53
One‐year cognitive follow‐up of COVID‐19 hospitalized patients	53
Myopathy as a cause of fatigue in long‐term post‐COVID‐19 symptoms: Evidence of skeletal muscle histopathology	52
Rapid onset of functional tic‐like behaviours in young adults during the COVID‐19 pandemic	50
Early data on long‐term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: a 2‐year update from the open‐label extension of the NEURO‐TTR trial	50
Miller‐Fisher syndrome after COVID‐19: neurochemical markers as an early sign of nervous system involvement	48
Safety of the BNT162b2 COVID‐19 vaccine in multiple sclerosis (MS): Early experience from a tertiary MS center in Israel	48
Subthalamic beta band suppression reflects effective neuromodulation in chronic recordings	47
Functional motor disorders associated with other neurological diseases: Beyond the boundaries of “organic” neurology	46
Female reproductive factors and the risk of dementia: a nationwide cohort study	46
Clinical characteristics and outcomes of thymoma‐associated myasthenia gravis	44
Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3‐month observational, longitudinal, cohort, multicenter, Italian real‐life study	44
Severe acute respiratory syndrome coronavirus 2 may be an underappreciated pathogen of the central nervous system	44
Headache during SARS‐CoV‐2 infection as an early symptom associated with a more benign course of disease: a case–control study	44
Minocycline in neurodegenerative and psychiatric diseases: An update	43
Altered motor cortex physiology and dysexecutive syndrome in patients with fatigue and cognitive difficulties after mild COVID‐19	43
Blood–brain barrier leakage and hemorrhagic transformation: The Reperfusion Injury in Ischemic StroKe (RISK) study	43
Guillain‐Barré syndrome in a patient with antibodies against SARS‐COV‐2	43
COVID‐19 pandemic and mental distress in multiple sclerosis: Implications for clinical management	42
Unraveling the enigma of new‐onset refractory status epilepticus: a systematic review of aetiologies	41
Dysphagia in COVID‐19 –multilevel damage to the swallowing network?	41
Guillain–Barré syndrome after SARS‐CoV‐2 infection	40
Olfactory bulb and mucosa abnormalities in persistent COVID‐19‐induced anosmia: a magnetic resonance imaging study	40
Trimethylamine‐N‐oxide is elevated in the acute phase after ischaemic stroke and decreases within the first days	40
Distal hereditary motor neuropathies: Mutation spectrum and genotype–phenotype correlation	40
Predictive factors of smell recovery in a clinical series of 288 coronavirus disease 2019 patients with olfactory dysfunction	39
Myasthenia gravis associated with anti‐MuSK antibodies developed after SARS‐CoV‐2 infection	38
International online survey of 1048 individuals with functional neurological disorder	37
COVID‐19: what if the brain had a role in causing the deaths?	36
Blood biomarkers and prognosis of amyotrophic lateral sclerosis	36
The European Academy of Neurology Brain Health Strategy: One brain, one life, one approach	35
The need for neurologists in the care of COVID‐19 patients	35
Perceived stress and social support in a large population of people with multiple sclerosis recruited online through the COVID‐19 pandemic	34
Relationship between COVID‐19 and movement disorders: A narrative review	34
Cross‐sectional area reference values for peripheral nerve ultrasound in adults: a systematic review and meta‐analysis—Part I: Upper extremity nerves	34
Assessment of neurological manifestations in hospitalized patients with COVID‐19	34

Declining mortality of cerebral venous sinus thrombosis with thrombocytopenia after SARS‐CoV‐2 vaccination	34
Automated speech analysis in early untreated Parkinson's disease: Relation to gender and dopaminergic transporter imaging	34
CADASIL: yesterday, today, tomorrow	34
Cognitive sequelae of long COVID may not be permanent: A prospective study	33
Dysphagia, dysarthria and aphasia following a first acute ischaemic stroke: incidence and associated factors	33
CD8+ T‐cell predominance in autoimmune glial fibrillary acidic protein astrocytopathy	33
Treatment with the monoclonal calcitonin gene‐related peptide receptor antibody erenumab: A real‐life study	33
Bilateral facial nerve palsy associated with COVID‐19 and Epstein–Barr virus co‐infection	32
Minor hallucinations reflect early gray matter loss and predict subjective cognitive decline in Parkinson's disease	32
Plasma neurofilament light chain as a potential biomarker in Charcot‐Marie‐Tooth disease	32
Muscle involvement in SARS‐CoV‐2 infection	32
The European Academy of Neurology COVID‐19 registry (ENERGY): an international instrument for surveillance of neurological complications in patients with COVID‐19	32
Lack of dyspnea in patients with Covid‐19: another neurological conundrum?	32
Lee Silverman Voice Treatment for dysarthria in patients with Parkinson’s disease: a systematic review and meta‐analysis	32
Neurophysiological investigations of drug resistant epilepsy patients treated with vagus nerve stimulation to differentiate responders from non‐responders	32
Daratumumab for treatment‐refractory antibody‐mediated diseases in neurology	31
Fatigue in multiple sclerosis patients with different clinical phenotypes: a clinical and magnetic resonance imaging study	31
Intracranial aneurysm wall enhancement as an indicator of instability: a systematic review and meta‐analysis	31
Epstein–Barr virus infection after adolescence and human herpesvirus 6A as risk factors for multiple sclerosis	31
Hypomimia in Parkinson’s disease: an axial sign responsive to levodopa	31
Correlation between total homocysteine and cerebral small vessel disease: A Mendelian randomization study	31
Ischaemic stroke in the time of coronavirus disease 2019	30
Diagnosis and prevalence of diabetic polyneuropathy: a cross‐sectional study of Danish patients with type 2 diabetes	30
Maintenance of response and predictive factors of 1‐year GalcanezumAb treatment in real‐life migraine patients in Italy: The multicenter prospective cohort GARLIT stud	30
COVID‐19 meningitis without pulmonary involvement with positive cerebrospinal fluid PCR	30
Systematic review of cases of acute myelitis in individuals with COVID‐19	29
SARS‐CoV‐2–associated Guillain‐Barre syndrome in 62 patients	29
Predictors of sustained response and effects of the discontinuation of anti‐calcitonin gene related peptide antibodies and reinitiation in resistant chronic migraine	28
Acute cerebellar ataxia and myoclonus with or without opsoclonus: a para‐infectious syndrome associated with COVID‐19	28
Using machine learning to predict stroke‐associated pneumonia in Chinese acute ischaemic stroke patients	28
A novel nomogram to predict early neurological deterioration in patients with acute ischaemic stroke	28
Inhibitory synapse loss and accumulation of amyloid beta in inhibitory presynaptic terminals in Alzheimer's disease	28
Concomitant brain arterial and venous thrombosis in a COVID‐19 patient	28
European Academy of Neurology and European Federation of Neurorehabilitation Societies guideline on pharmacological support in early motor rehabilitation after acute ischaemic stroke	28
Neurological complications of COVID‐19 in hospitalized patients: The registry of a neurology department in the first wave of the pandemic	28
The Framingham cardiovascular risk score and 5‐year progression of multiple sclerosis	28
Impact of COVID‐19 outbreak in reperfusion therapies of acute ischaemic stroke in northwest Spain	28
Usability of the head impulse test in routine clinical practice in the emergency department to differentiate vestibular neuritis from stroke	28
The long‐term outcome of MOGAD: An observational national cohort study of 61 patients	27
Multiple sclerosis and COVID‐19: How many are at risk?	27
Early shunt surgery improves survival in idiopathic normal pressure hydrocephalus	27
Chronic immunoglobulin maintenance therapy in myasthenia gravis	27
Association between neuropathy and B‐vitamins: A systematic review and meta‐analysis	27
Socioeconomic impact of restless legs syndrome and inadequate restless legs syndrome management across European settings	27
Endovascular treatment for basilar artery occlusion: A systematic review and meta‐analysis	26
Altered resting‐state functional connectivity between subregions in the thalamus and cortex in migraine without aura	26
Healthcare costs of post‐stroke oropharyngeal dysphagia and its complications: malnutrition and respiratory infections	26
Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo‐controlled, dose‐finding trial followed by 24 months of treatment	26
Emerging concepts on bradykinesia in non‐parkinsonian conditions	26
Optical coherence tomography measurements as potential imaging biomarkers for Parkinson's disease: A systematic review and meta‐analysis	26
Risk and outcomes of COVID‐19 in patients with multiple sclerosis	26
The etiology of rhabdomyolysis: an interaction between genetic susceptibility and external triggers	26
Tau and neurofilament light‐chain as fluid biomarkers in spinocerebellar ataxia type 3	26
Clinic and genetic predictors in response to erenumab	26
Molecular analysis and clinical diversity of distal hereditary motor neuropathy	26
Cognitive frailty and falls in Chinese elderly people: a population‐based longitudinal study	26
Antiherpetic medication and incident dementia: Observational cohort studies in four countries	25
Relationships between retinal layer thickness and brain volumes in the UK Biobank cohort	25
Large vessel occlusion is independently associated with atrial fibrillation detection	25
Cognitive processing speed in multiple sclerosis clinical practice: association with patient‐reported outcomes, employment and magnetic resonance imaging metrics	25
Cerebrospinal and blood levels of amino acids as potential biomarkers for Parkinson’s disease: review and meta‐analysis	25
Endovascular therapy versus no endovascular therapy in patients receiving best medical management for acute isolated occlusion of the posterior cerebral artery: A systematic review and meta‐analy	25
Nitrous oxide‐induced myeloneuropathy	25
Functional connectivity and topology in patients with restless legs syndrome: a case–control resting‐state functional magnetic resonance imaging study	25
European Society for the Study of Tourette Syndrome 2022 criteria for clinical diagnosis of functional tic‐like behaviours: International consensus from experts in tic disorders	25
Is there evidence of bradykinesia in essential tremor?	24
Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosis	24
The spectrum of functional tic‐like behaviours: Data from an international registry	24
Efficacy and safety of rituximab in myasthenia gravis: a French multicentre real‐life study	24
Machine‐learning‐based outcome prediction in stroke patients with middle cerebral artery‐M1 occlusions and early thrombectomy	24
Physical and cognitive profiles in motoric cognitive risk syndrome in an older population from Southern Italy	24
European Neuromuscular Centre consensus statement on anaesthesia in patients with neuromuscular disorders	23
Charcot–Marie–Tooth disease misdiagnosed as chronic inflammatory demyelinating polyradiculoneuropathy: An international multicentric retrospective study	23
EAN consensus statement for management of patients with neurological diseases during the COVID‐19 pandemic	23
Misdiagnosis and diagnostic pitfalls of chronic inflammatory demyelinating polyradiculoneuropathy	23
Neurofilament light chain and total tau in the differential diagnosis and prognostic evaluation of acute and chronic inflammatory polyneuropathies	23
European Academy of Neurology/Movement Disorder Society ‐ European Section guideline on the treatment of Parkinson's disease: I. Invasive therapies	23
Clinical and radiological profile of patients with spinal muscular atrophy type 4	23
Non‐invasive and tracheostomy invasive ventilation in amyotrophic lateral sclerosis: Utilization and survival rates in a cohort study over 12 years in Germany	23
Sex differences in acute ischaemic stroke patients: clinical presentation, causes and outcomes	23

Skin amyloid deposits and nerve fiber loss as markers of neuropathy onset and progression in hereditary transthyretin amyloidosis	23
Safety and tolerability of SARS‐Cov‐2 vaccination in patients with myasthenia gravis: A multicenter experience	23
Neurological symptoms and complications in predominantly hospitalized COVID‐19 patients: Results of the European multinational Lean European Open Survey on SARS‐Infected Patients (LEOSS)	23
Meningitis due to cerebrospinal fluid leak after nasal swab testing for COVID‐19	22
Persistent visual dysfunction following posterior reversible encephalopathy syndrome due to COVID‐19: Case series and literature review	22
Expanding the clinical spectrum of anti‐IgLON5 disease: A multicenter retrospective study	22
Functional neurological disorders presenting as emergencies to secondary care	22
Risk factors for 2‐year mortality in patients with prolonged disorders of consciousness: An international multicentre study	22
Gut microbiota and metabolome distinctive features in Parkinson disease: Focus on levodopa and levodopa‐carbidopa intrajejunal gel	22
KCNN2 mutation in autosomal‐dominant tremulous myoclonus‐dystonia	22
Progressive supranuclear palsy often develops idiopathic normal pressure hydrocephalus‐like magnetic resonance imaging features	22
EAN guideline on palliative care of people with severe, progressive multiple sclerosis	22
Guillain‐Barré syndrome and COVID‐19: A 1‐year observational multicenter study	22
A full year of the COVID‐19 pandemic with two infection waves and its impact on ischemic stroke patient care in Germany	22
Insomnia disorder: clinical and research challenges for the 21st century	22
Pioglitazone and statins lower incidence of Parkinson disease in patients with diabetes mellitus	21
Is there a correlation between MOG‐associated disorder and SARS‐CoV‐2 infection?	21
Prognosis and risk factors associated with asymptomatic intracranial hemorrhage after endovascular treatment of large vessel occlusion stroke: a prospective multicenter cohort study	21
Differences in neurology residency training programmes across Europe – a survey among the Residents and Research Fellow Section of the European Academy of Neurology national representatives	21
Thrombolysis and bridging therapy in patients with acute ischaemic stroke and Covid‐19	21
Clinical presentation and management strategies of cardiovascular autonomic dysfunction following a COVID‐19 infection – A systematic review	21
Association between depression and motoric cognitive risk syndrome among community‐dwelling older adults in China: A 4‐year prospective cohort study	21
Glymphatic dysfunction correlates with severity of small vessel disease and cognitive impairment in cerebral amyloid angiopathy	21
Moyamoya disease in a European setting: a Danish population‐based study	21
Worldwide barriers to genetic testing for movement disorders	21
Optical coherence tomography measures correlate with brain and spinal cord atrophy and multiple sclerosis disease‐related disability	21
Inner retinal layer thinning in radiologically isolated syndrome predicts conversion to multiple sclerosis	21
Brain age as a surrogate marker for cognitive performance in multiple sclerosis	21
Early neurological deterioration following thrombolysis for minor stroke with isolated internal carotid artery occlusion	21
Cross‐sectional area reference values for peripheral nerve ultrasound in adults: A systematic review and meta‐analysis—Part II: Lower extremity nerves	21
Minimal clinically important differences in functional motor scores in adults with spinal muscular atrophy	21
Protective factors for subjective cognitive decline individuals: trajectories and changes in a longitudinal study with Italian elderly	21
Aggressive multiple sclerosis: a single‐centre, real‐world treatment experience with autologous haematopoietic stem cell transplantation and alemtuzumab	20
Standard procedures for the diagnostic pathway of sleep‐related epilepsies and comorbid sleep disorders: an EAN, ESRS and ILAE‐Europe consensus review	20
Cytomegalovirus seropositivity is associated with reduced risk of multiple sclerosis—a presymptomatic case–control study	20
Functional connectivity changes in complex migraine aura: beyond the visual network	20
Tau protein as a diagnostic and prognostic biomarker in amyotrophic lateral sclerosis	20
Distinct intra‐arterial clot localization affects tissue‐level collaterals and venous outflow profiles	20
Association of short‐term exposure to ambient air pollution with mortality from ischemic and hemorrhagic stroke	20
Gastrointestinal barriers to levodopa transport and absorption in Parkinson's disease	20
Prevalence and factors associated with motoric cognitive risk syndrome in community‐dwelling older Chinese: a cross‐sectional study	20
Migraine prevalence in visual snow with prior illicit drug use (hallucinogen persisting perception disorder) versus without	20
Brain volume loss due to donanemab	20
B‐type natriuretic peptide over N‐terminal pro‐brain natriuretic peptide to predict incident atrial fibrillation after cryptogenic stroke	20
Quantifying the risk of disease reactivation after interferon and glatiramer acetate discontinuation in multiple sclerosis: The VIAADISC score	20
European Academy of Neurology/European Alzheimer’s Disease Consortium position statement on diagnostic disclosure, biomarker counseling, and management of patients with mild cognitive impairment	19
The prevalence of hypertension in multiple sclerosis based on 37 million electronic health records from the United States	19
Estimating the savings associated with a migraine‐free life: results from the Spanish Atlas	19
The core/penumbra model: implications for acute stroke treatment and patient selection in 2021	19
Non‐alcoholic fatty liver disease and stroke: A Mendelian randomization study	19
Social cognition in cervical dystonia: phenotype and relationship to anxiety and depression	19
Altered ioflupane single‐photon emission computed tomography in anti‐IgLON5 disease: A new case mimicking probable progressive supranuclear palsy and review of the literature	19
Delirium in acute stroke: A prospective, cross‐sectional, cohort study	19
Admission computed tomography radiomic signatures outperform hematoma volume in predicting baseline clinical severity and functional outcome in the ATACH‐2 trial intracerebral hemorrhage population	19
Early diagnosis of amyotrophic lateral sclerosis by threshold tracking and conventional transcranial magnetic stimulation	19
Atrial fibrosis in embolic stroke of undetermined source: A multicenter study	19
Speech metrics, general disability, brain imaging and quality of life in multiple sclerosis	19
Reply to letter on Acute‐onset smell and taste disorders in the context of COVID‐19: a pilot multicentre polymerase chain reaction based case–control study	19
Ischemic stroke in COVID‐19 patients: Mechanisms, treatment, and outcomes in a consecutive Swiss Stroke Registry analysis	19
Short‐ and long‐term outcome and predictors in an international cohort of patients with neuro‐COVID‐19	19
Predicting atrial fibrillation after cryptogenic stroke via a clinical risk score—a prospective observational study	19
Headache at onset of first‐ever ischemic stroke: Clinical characteristics and predictors	19
Box and block test, hand grip strength and nine‐hole peg test: correlations between three upper limb objective measures in multiple sclerosis	19
Exploratory pilot study of exogenous sustained‐release melatonin on nocturia in Parkinson's disease	19
First‐line therapies in late‐onset multiple sclerosis: An Italian registry study	18
Status epilepticus with prominent motor symptoms clusters into distinct electroclinical phenotypes	18
Genotype and phenotype distribution of 435 patients with Charcot–Marie–Tooth disease from central south China	18
The Unruptured Intracranial Aneurysm Treatment Score as a predictor of aneurysm growth or rupture	18
Data‐driven machine‐learning analysis of potential embolic sources in embolic stroke of undetermined source	18
Dural arteriovenous fistulas in cerebral venous thrombosis	18
Incidence of motor neuron disease/amyotrophic lateral sclerosis in South Africa: a 4‐year prospective study	18
Effects of exergaming on hippocampal volume and brain‐derived neurotrophic factor levels in Parkinson’s disease	18
Higher‐quality diet and non‐consumption of meat are associated with less self‐determined disability progression in people with multiple sclerosis: A longitudinal cohort study	18
Benefit of first‐pass complete reperfusion in thrombectomy is mediated by limited infarct growth	18
Efficacy of innovative therapies in myasthenia gravis: A systematic review, meta‐analysis and network meta‐analysis	18
Bruns' nystagmus revisited: A sign of stroke in patients with the acute vestibular syndrome	18
A multicenter study of transient global amnesia for the better detection of magnetic resonance imaging abnormalities	18
Risk of intracranial meningioma with three potent progestogens: A population‐based case–control study	18
Partial and nonresponders to onabotulinumtoxinA can benefit from anti‐CGRP monoclonal antibodies preventive treatment: A real‐world evidence study	18
Nonalcoholic fatty liver disease, serum cytokines, and dementia among rural‐dwelling older adults in China: A population‐based study	17
Statins, diabetes mellitus and prognosis of amyotrophic lateral sclerosis: data from 501 patients of a population‐based registry in southwest Germany	17
Corneal sub‐basal whorl‐like nerve plexus: a landmark for early and follow‐up evaluation in transthyretin familial amyloid polyneuropathy	17
Bi‐hemispheric transcranial direct current stimulation for upper‐limb hemiparesis in acute stroke: a randomized, double‐blind, sham‐controlled trial	17
Neuronal intranuclear inclusion disease tremor‐dominant subtype: A mimicker of essential tremor	17
Incidence and risk of cancer among multiple sclerosis patients: A matched population‐based cohort study	17
Rapid screening for neglect following stroke: A systematic search and European Academy of Neurology recommendations	17
Immunomodulatory treatment in postural tachycardia syndrome: A case series	17
Sensitized rotatory motion perception and increased susceptibility to motion sickness in vestibular migraine: A cross‐sectional study	17
The severity of neuropsychiatric symptoms is higher in early‐onset than late‐onset Alzheimer’s disease	17
Health‐related quality of life and functional impairment in acute vestibular disorders	17
Video quality using outpatient smartphone videos in epilepsy: Results from the OSmartViE study	17
Facial nerve palsy: an atypical clinical manifestation of COVID‐19 infection in a family cluster	17
Progression of fatigue in Parkinson’s disease – a 9‐year follow‐up	16
Cranial nerve involvement in typical and atypical chronic inflammatory demyelinating polyneuropathies	16
Unblinded by the light: amyloid‐related imaging abnormalities in Alzheimer’s clinical trials	16